Assessment of inhaled BDP-dose dependency of exhaled nitric oxide and local and serum eosinophilic markers in steroids-naive nonatopic asthmatics

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 58, Issue 10, 2003, Pages 1018-1022

  Dal Negro, R ^a,c   Micheletto, C ^a   Tognella, S ^a   Turco, P ^a   Rossetti, A ^b   Cantini, L ^b  

^a Bussolengo Hospital   (Italy)

^b CHIESI FARMACEUTICI S P A   (Italy)

^c Ospedale 2   (Italy)

Author keywords

Eosinophil cationic protein; Eosinophils; Forced expiratory volume in 1 s; Induced sputum; Nitric oxide

Indexed keywords

BECLOMETASONE DIPROPIONATE; BIOLOGICAL MARKER; CLENIL P; EOSINOPHIL CATIONIC PROTEIN; NITRIC OXIDE; STEROID;

ADULT; AIRWAY; ALLERGIC ASTHMA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DOSE RESPONSE; DRUG MEGADOSE; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; LUNG FUNCTION TEST; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SPUTUM; SPUTUM LEVEL;

ADMINISTRATION, INHALATION; ASTHMA; BECLOMETHASONE; BIOLOGICAL MARKERS; BLOOD PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; EOSINOPHIL GRANULE PROTEINS; EOSINOPHILS; EXHALATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; PULMONARY EOSINOPHILIA; RIBONUCLEASES; SPUTUM;

EID: 0141887564     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2003.00229.x     Document Type: Article

References (20)

1. BOUSQUET J, CHANEZ P, LACOSTE JY, BARNEON G, GHAVANIAN N, ENANDER I et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-1039.
2. HAKANSSON L, RAK S, VENGE P. The formation of eosinophil and neutrophil chemotactic activity during a pollen season and after allergen challenge. J Allergy Clin Immunol 1989;83:933-939.
3. WILSON AM, LIPWORTH BJ. Dose-response evaluation of the therapeutic index for inhaled budesonide in patients with mild-to-moderate asthma. Am J Med 2000;108:269-275.
4. 20, and exacerbations. Respir Med 1994;88:613-621.
5. PIZZICHINI E, PIZZICHINI MM, EFTHIMIADIS A, DOLOVICH J, HARGREAVE FE. Measuring airway inflammation in asthma: eosinophils and eosinophilic cationic protein in induced sputum compared with peripheral blood. J Allergy Clin Immunol 1997;99: 539-544.
6. VIRCHOW JC, HOLSCHER U, VIRCHOW C. Sputum ECP levels correlate with parameters of airflow obstruction. Am Rev Respir Dis 1992;146:604-606.
7. TSUJINO I, NISHIMURA M, KAMACHI A, MAKITA H, MUNAKATA M, MIYAMOTO K et al. Exhaled nitric oxide - is it really a good marker of airway inflammation in bronchial asthma? Respiration 2000;67:645-651.
8. BERLYNE GS, PARAMESWARAN K, KAMADA D, EFTHIAMIADIS A, HARGREAVE FE. A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation. J Allergy Clin Immunol 2000;106:638-644.
9. AL-ALI MK, EAMES C, HOWARTH PH. Exhaled nitric oxide; relationship to clinic-physiological markers of asthma severity. Respir Med 1998;92:908-913.
10. LUDVIKSDOTTIR D, JANSON C, HOGMAN M, HEDENSTROM H, BJORNSSON E, BOMAN G. Exhaled nitric oxide and its relationship to airway responsiveness and atopy in asthma. BHR-Study Group. Respir Med 1999;93:552-556.
11. GRIESE M, KOCH M, LATZIN P, BECK J. Asthma severity, recommended changes of inhaled therapy and exhaled nitric oxide in children: a prospective, blinded trial. Eur J Med Res 2000;5:334-340.
12. Global Initiative for asthma. Global strategy for asthma management and prevention. NHLBI/WHO Workshop report Publication Number 95-3659, January 1995.
13. DAL NEGRO R, MICHELETTO C, TOGNELLA S, CLAYTON N, CANTINI L, WOODCOCK A. Evidence of adequacy of the performance of the Pulvinal™ by measuring through-device peak inspiratory flow rate in severe airways obstruction in adults and children. J Aerosol Med 2001;14:343-349.
14. QUANJER PhH, TAMMELING GJ, COTES JE, PEDERSEN OF, PESLIN R. Lung volumes and forced ventilatory flows. Eur Respir J 1993;6:5-40.
15. MICHELETTO C, BURTI E, MAURONER L, POMARI C, TOGNELLA S, DAL NEGRO R. Interferenze sulla misura dell' ECP sierica dovuta alla variazione termica durante la fase di clotting. Medicina Toracica 1997;19:181-185.
16. PIN I, GIBSON PG, KOLENDOWICZ R, GIRBIS-GABARDO A, DENBURG JA, HARGREAVE FE et al. Use of induced sputum cell counts to investigate airway inflammation in asthma Thorax 1992;47:25-29.
17. DAL NEGRO R, MICHELETTO C, TOGNELLA S, MAURONER L, BURTI E, TURCO P et al. Effect of inhaled beclomethasone dipropionate and budesonide dry powder on pulmonary function and serum eosinophil cationic protein in adult asthmatics. Invest Allergol Clin Immunol 1999;9:241-247.
18. WILSON NM, BRIDGE P, SPANEVELLO A, SILVERMAN M. Induced sputum in children: feasibility, repeatability and relation of findings to asthma severity. Thorax 2000;55:768-774.
19. PIACENTINI GL, BODINI A, COSTELLA S, SUZUKI Y, ZERMAN L, PETERSON CG et al. Exhaled nitric oxide, serum ECP and airway responsiveness in mild asthmatic children. Eur Respir J 2000;15:839-843.
20. ASHUTOSH K. Nitric oxide and asthma: a review. Curr Opin Pulm Med 2000;6:21-25.